What Is the Recommended Approach After Resection of Stage IIA Melanoma?

Following curative-intent surgery for stage IIA melanoma, clinicians face a critical decision: whether to initiate adjuvant therapy. Evidence-based guidance provides a specific, strongly recommended direction for this post-resection scenario.

Clinical scenario Patient with resected stage IIA melanoma — considering adjuvant therapy after complete surgical resection.

Protocol overview The protocol defines clear guidance on the role of adjuvant therapy in this specific setting, distinguishing routine clinical practice from conditions involving trial participation. The complete structured recommendations are available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

Adjuvant therapy should not be offered to patients with resected stage IIA melanoma outside of enrollment in a clinical trial (Type: Informal consensus; Evidence quality: Not applicable; Strength of Recommendation: Strong).

View source ↗